233
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies

ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 11535-11550 | Received 05 Jul 2022, Accepted 26 Dec 2022, Published online: 08 Jan 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mohammed A. Dahab, Hazem A. Mahdy, Hazem Elkady, Mohammed S. Taghour, Alaa Elwan, Mohamed A. Elkady, Elsayed G. E. Elsakka, Eslam B. Elkaeed, Aisha A. Alsfouk, Ibrahim M. Ibrahim, Ahmed M. Metwaly & Ibrahim H. Eissa. (2023) Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluations. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-20.
Read now

Articles from other publishers (2)

José-Luis Rodríguez, Raquel Mateos, Olga Palomino, Maria S. Fernández-Alfonso, Norma Ramos-Cevallos, Luis Inostroza-Ruiz, Nadia Panduro-Tenazoa, Wendy Bada-Laura, Noé Ramírez-Flores & Luis Goya. (2023) Cytoprotective–Antioxidant Effect of Brunfelsia grandiflora Extract on Neuron-like Cells. Applied Sciences 13:22, pages 12233.
Crossref
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, Eslam B. Elkaeed, Bshra A. Alsfouk, Dalal Z. Husein, Mostafa A. Asmaey, Ibrahim M. Ibrahim & Ahmed M. Metwaly. (2023) Anti-breast cancer potential of a new xanthine derivative: In silico, antiproliferative, selectivity, VEGFR-2 inhibition, apoptosis induction and migration inhibition studies. Pathology - Research and Practice 251, pages 154894.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.